Indaptus Therapeutics (NASDAQ: INDP) seeks approval for 2026 equity plan
Indaptus Therapeutics (NASDAQ: INDP) is seeking shareholder approval for its 2026 Equity Incentive Plan at the upcoming annual meeting on August 10, 2026. The plan will initially reserve 13,324,232 shares and includes an annual automatic increase of 5% of outstanding shares from 2027 through …